Neovasc Inc Revenue Growth Rates (NVCN), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Neovasc Inc   (NASDAQ: NVCN)
 

NVCN's Revenue Growth by Quarter and Year

Neovasc Inc 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

NVCN Revenue (in millions $) FY 2021 FY 2020 FY 2019 FY 2018
4th Quarter December 2.55
3rd Quarter September 0.00
2nd Quarter June 0.00
1st Quarter March 0.00
FY 2.55

NVCNs Annual Revenue
Neovasc Inc 's Revenue in the fiscal year 2021 $ 2.55 millions
Neovasc Inc 's Revenue in the fiscal year 2020 $ 1.96 millions
Neovasc Inc 's Revenue in the fiscal year 2019 $ 2.09 millions
Neovasc Inc 's Revenue in the fiscal year 2018 $ 1.75 millions
Neovasc Inc 's Revenue in the fiscal year 2017 $ 5.39 millions




NVCN Revenue fourth quarter 2021 Y/Y Growth Comment
Neovasc Inc achieved in the fourth quarter 2021, above Company average Revenue growth of 21.89% year on year, to $ 2.55 millions.

Looking into fourth quarter 2021 results within Medical Equipment & Supplies industry 72 other companies have achieved higher Revenue growth. While Neovasc Inc ' s Revenue rise of 21.89% ranks overall at the positon no. 1845 in the fourth quarter 2021.


NVCN Revenue ( Y/Y Growth %) 2021
 2020 2019 2018
4th Quarter December 21.89 % 19.43 % - -
3rd Quarter September - - - -
2nd Quarter June - - - -
1st Quarter March - - - -
FY   21.89 % 19.43 % - -

Financial Statements
Neovasc Inc 's fourth quarter 2021 Revenue $ 2.55 millions NVCN's Income Statement
Neovasc Inc 's fourth quarter 2020 Revenue $ 2.09 millions Quarterly NVCN's Income Statement


NVCN Revenue (Quarter on Quarter Growth %)

 2021
 2020 2019 2018
4th Quarter December - - - -
3rd Quarter September - - - -
2nd Quarter June - - - -
1st Quarter March - - - -
FY (Year on Year)   21.89 % 19.43 % - -


Back to NVCN Growth rate Comparisons >> Back to NVCN Growth rate Comparisons >>


Revenue fourth quarter 2021 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #73
Healthcare Sector #293
Overall #1845

Revenue Y/Y Growth Statistics
High Average Low
19.6 % 19.6 % 19.6 %
(Dec 31 2019)  
Revenue fourth quarter 2021 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #73
Healthcare Sector #293
Overall #1845
Revenue Y/Y Growth Statistics
High Average Low
19.6 % 19.6 % 19.6 %
(Dec 31 2019)  

Revenue by Quarter for the Fiscal Years 2018, 2019, 2020, 2021

Neovasc Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


NVCN's IV. Quarter Q/Q Revenue Comment


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #
Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


NVCN's IV. Quarter Q/Q Revenue Comment


Neovasc Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Dec 31 2021)		 12 Months Ending
(Dec 31 2020)		 12 Months Ending
(Dec 31 2019)		 12 Months Ending
(Dec 31 2018)		 12 Months Ending
Cumulative Revenue 12 Months Ending $ 2.55 $ 1.96 $ 2.09 $ 1.75 $ 0.00
Y / Y Revenue Growth (TTM) 30.14 % -6.44 % 19.6 % -67.54 % -
Year on Year Revenue Growth Overall Ranking # 1825 # 0 # 0 # 0 # 0
Seqeuential Revenue Change (TTM) 30.14 % -6.44 % 19.6 % -67.54 % -
Seq. Revenue Growth (TTM) Overall Ranking # 1825 # 0 # 0 # 0 # 0


Cumulative Revenue growth Comment
Neovasc Inc saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 30.14% year on year, to $ 3 millions if the fiscal year would have ended in Dec 31 2021.
Neovasc Inc 's trailing twelve months Revenue growth was higher than company's average 20.69% and higher than -6.44% growth in Dec 31 2020.
The momentum is even more impressive from twelve months ended Dec 31 2020 exhibited at 30.14 % increase from $1.96 millions in the period from Dec 31 2020 to .

In the Healthcare sector 274 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 0 to 1825.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 75
Healthcare Sector # 275
Overall # 1825

Revenue TTM Y/Y Growth Statistics
High Average Low
21.77 %
 20.69 %
19.6 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 75
Sector # 275
S&P 500 # 1825
Cumulative Revenue growth Comment
Neovasc Inc saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 30.14% year on year, to $ 3 millions if the fiscal year would have ended in Dec 31 2021.
Neovasc Inc 's trailing twelve months Revenue growth was higher than company's average 20.69% and higher than -6.44% growth in Dec 31 2020.
The momentum is even more impressive from twelve months ended Dec 31 2020 exhibited at 30.14 % increase from $1.96 millions in the period from Dec 31 2020 to .

In the Healthcare sector 274 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 0 to 1825.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 75
Healthcare Sector # 275
Overall # 1825

Revenue TTM Y/Y Growth Statistics
High Average Low
21.77 %
20.69 %
19.6 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 75
Sector # 275
S&P 500 # 1825




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
NVCN's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue rise for the quarter ending Dec 31 2021 within Healthcare SectorY/Y Change %Revenue for the quarter ending Dec 31 2021
Guardant Health Inc 38.04%$ 38.041 millions
Optinose Inc 37.69%$ 37.695 millions
Lantheus Holdings Inc 37.61%$ 37.609 millions
Syros Pharmaceuticals Inc 36.93%$ 36.925 millions
Horizon Therapeutics Public Limited Company36.11%$ 36.112 millions
Global Blood Therapeutics Inc.35.85%$ 35.849 millions
Solana Company35.79%$ 35.789 millions
Summit Therapeutics Inc 35.68%$ 35.676 millions
Insmed Inc35.52%$ 35.516 millions
Lensar Inc 35.47%$ 35.466 millions
Skinvisible Inc 35.32%$ 35.325 millions
Caredx Inc 35.09%$ 35.086 millions
Strata Skin Sciences Inc34.84%$ 34.837 millions
Jazz Pharmaceuticals Plc34.74%$ 34.742 millions
Arbutus Biopharma Corp34.37%$ 34.367 millions
Silk Road Medical Inc 33.75%$ 33.748 millions
Catalent Inc 33.62%$ 33.619 millions
Oak Street Health Inc 33.45%$ 33.447 millions
Redhill Biopharma Ltd 33.25%$ 33.248 millions
Fortress Biotech Inc 32.93%$ 32.926 millions
Vivos Therapeutics Inc 32.89%$ 32.894 millions
Pacific Biosciences Of California Inc 32.28%$ 32.282 millions
Bioventus Inc 32.28%$ 32.278 millions
Igc Pharma Inc 31.48%$ 31.481 millions
Cutera Inc 31.41%$ 31.408 millions
Electromedical Technologies Inc 31.26%$ 31.264 millions
Orthopediatrics Corp31.12%$ 31.119 millions
Vaso Corporation31.07%$ 31.065 millions
Establishment Labs Holdings Inc 30.97%$ 30.968 millions
Xoma Royalty Corporation30.33%$ 30.326 millions


About Neovasc Inc Revenue Growth Rates (NVCN), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Neovasc Inc (CIK 1399708).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001104659-22-032437
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Neovasc Inc’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.